COPD research is top
4 March 2010
Research into serious lung diseases at Imperial has been rated the most highly cited in the world by the information provider Thomson Reuters.
The organisation looked at published academic research into Chronic Obstructive Pulmonary Disease (COPD), a group of progressive inflammatory conditions that includes emphysema and chronic obstructive bronchitis.
In the UK, COPD affects around one in ten adults over the age of 40 and it kills more women than breast cancer. It causes the airways to become narrowed, leading to shortness of breath, and the condition is hard to treat so it usually becomes progressively worse. In the developed world, most people contract COPD through smoking.
Thomson Reuters analysed papers on COPD published over a ten-year period by nearly 10,000 institutions across 113 countries. The results, published on the ScienceWatch website, show that Imperial achieved more citations for COPD than any other institution. In addition, Professor Peter Barnes, the Head of Airway Disease (NHLI), achieved more citations for his work on COPD than any other researcher in the world.
To listen to Professor Peter Barnes explaining more about COPD and how researchers at Imperial are tackling the disease, visit http://www3.imperial.ac.uk/news/lungdiseases
— Laura Gallagher, Communications